Breast cancer lung metastasis: Molecular biology and therapeutic implications-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Breast cancer lung metastasis: Molecular biology and therapeutic implications

Published:2018-04-30 Issue:10 Volume:19 Page:858-868
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Jin Liting¹,Han Bingchen²,Siegel Emily²,Cui Yukun³,Giuliano Armando²,Cui Xiaojiang²

Affiliation:

1. Department of Breast Surgery, Hubei Cancer Hospital, Wuhan, China

2. Department of Surgery, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA

3. Laboratory for Breast Cancer Diagnosis and Treatment, Cancer Hospital of Shantou University Medical College, Shantou, China

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384047.2018.1456599

Reference176 articles.

1. Breast cancer statistics, 2013

2. Tumor Metastasis: Molecular Insights and Evolving Paradigms

3. Strategies for the discovery and development of therapies for metastatic breast cancer

4. Hydrophobic interaction mediating self-assembled nanoparticles of succinobucol suppress lung metastasis of breast cancer by inhibition of VCAM-1 expression

5. Plantamajoside, a potential anti-tumor herbal medicine inhibits breast cancer growth and pulmonary metastasis by decreasing the activity of matrix metalloproteinase-9 and -2

Cited by 198 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Characterization of a Peptide-Bisphosphonate Nanoparticle for the Treatment of Breast Cancer;Molecular Pharmaceutics;2024-08-28

2. Prognostic and clinicopathological significance of fibrinogen-to-albumin ratio (FAR) in patients with breast cancer: a meta-analysis;World Journal of Surgical Oncology;2024-08-24

3. Inflammation drives tumor growth in an immunocompetent implantable metastasis model;2024-08-11

4. New uses of halofuginone to treat cancer;Journal of Pharmaceutical Analysis;2024-08

5. Local, Sustained, and Targeted Co-Delivery of MEK Inhibitor and Doxorubicin Inhibits Tumor Progression in E-Cadherin-Positive Breast Cancer;Pharmaceutics;2024-07-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3